1. (1)

   Neither this chapter nor Chapters 4, 5 or 6 of DTR shall apply in relation to an undertaking that falls within paragraph (2) or units of such an undertaking that fall within paragraph (3). [Note: article 1.2TD].

2. (2)

   The exemption set out in paragraph (1) applies to an undertaking if it is a unit trust or investment company

   1. (a)

      the object of which is the collective investment of capital provided by the public, and which operates on the principle of risk spreading; and

   2. (b)

      the units of which are, at the request of the holder of such units, repurchased or redeemed, directly or indirectly, out of the assets of that undertaking. [Note: article 2.1(g) TD]

3. (3)

   Units of an undertaking that falls within paragraph (2) are securities issued by such an undertaking and representing the rights of the participants in such an undertaking. [Note: article 2.1(h) TD]

1. (1)

   The FSA may dispense with, or modify, the transparency rules in such cases and by reference to such circumstances as it considers appropriate (subject to the terms of directives and the Act).

2. (2)

   A dispensation or modification may be either unconditional or subject to specified conditions.

3. (3)

   If an issuer, or other person has applied for, or been granted, a dispensation or modification, it must notify the FSA immediately it becomes aware of any matter which is material to the relevance or appropriateness of the dispensation or modification.

4. (4)

   The FSA may revoke or modify a dispensation or modification.

1. (1)

   An application to the FSA to dispense with or modify, a transparency rule must be in writing.

2. (2)

   The application must:

   1. (a)

      contain a clear explanation of why the dispensation or modification is requested;

   2. (b)

      include details of any special requirements, for example, the date by which the dispensation or modification is required;

   3. (c)

      contain all relevant information that should reasonably be brought to the FSA's attention;

   4. (d)

      contain any statement or information that is required by the transparency rules to be included for a specific type of dispensation or modification; and

   5. (e)

      include copies of all documents relevant to the application.

1. (1)

   The FSA may, at any time, require an issuer to publish such information in such form and within such time limits as it considers appropriate to protect investors or to ensure the smooth operation of the market.

2. (2)

   If an issuer fails to comply with a requirement under paragraph (1) the FSA may itself publish the information (after giving the issuer an opportunity to make representations as to why it should not be published).

An issuer must take all reasonable care to ensure that any information it notifies to a RIS is not misleading, false or deceptive and does not omit anything likely to affect the import of the information.

1The duty imposed by DTR 1A.3.2 R does not apply to an issuer's obligation under DTR 5.8.12 R to make public the information contained in a vote holder notification made to it under DTR 5.1.2 R.

If an issuer is required to notify information to a RIS at a time when a RIS is not open for business, it must distribute the information as soon as possible to:

1. (1)

   not less than two national newspapers in the United Kingdom;

2. (2)

   two newswire services operating in the United Kingdom; and

3. (3)

   a RIS for release as soon as it opens.

An issuer must pay the fees set out in DTR App 2R to the FSA when they are due.